Pharmacogenomics of Atherosclerotic Plaque: Pathophysiological Background and Therapeutic Perspectives. [PDF]
Mauriello A +6 more
europepmc +1 more source
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026. [PDF]
Ozaki Y +50 more
europepmc +1 more source
Adjusting Antiplatelet Therapy Using P2Y<sub>12</sub> Reaction Units in Endovascular Treatment of Unruptured Intracranial Aneurysms. [PDF]
Moon E +7 more
europepmc +1 more source
Bridging Technique with a Stent Retriever for Iatrogenic Internal Carotid Artery Occlusion during Coil Embolization of a Ruptured Aneurysm. [PDF]
Matsuishi M +5 more
europepmc +1 more source
Sex-Based Differences in the Effect of Short Dual Antiplatelet Therapy Followed by Prasugrel Monotherapy in High-Bleeding-Risk Patients After Percutaneous Coronary Intervention. [PDF]
Kogame N +9 more
europepmc +1 more source
Letter to the Editor regarding: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI". [PDF]
Umińska JM.
europepmc +1 more source
PANTHER: Prasugrel-based aneurysm treatment with non-identical telescoping with flow diversion with hydrophilic polymer coating for endovascular reconstruction in acute subarachnoid hemorrhage. [PDF]
Khanafer A +7 more
europepmc +1 more source
Cardiovascular Diseases: From Pathophysiology to Novel Therapeutic Approaches. [PDF]
Flora A, Fazio S.
europepmc +1 more source
In Hospital Assessment and Management of High Bleeding Risk in Patients with ST-Elevation Myocardial Infarction (STEMI). [PDF]
Kim S +8 more
europepmc +1 more source
Risk factors of bleeding in patients with atrial fibrillation undergoing percutaneous coronary intervention: an analysis from the MANJUSRI study. [PDF]
Li Y, Lu W, Wang Y, Chen L, Ma G.
europepmc +1 more source

